Long term prognosis of sarcoidosis in Arabs and Asians: Predictors of good outcome

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 23, Issue 3, 2006, Pages 209-214

  Behbehani, Nasser ^a   Jayakrishnan, Balakrishnan ^b   Khadadah, Mousa ^a   Al Sawi, Mohamed ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b Ministry of Public Health Kuwait   (Kuwait)

Author keywords

Arabs; Asians; Sarcoidosis

Indexed keywords

ADULT; ARAB; ARTHRALGIA; ARTICLE; ASIAN; COURSE EVALUATION; DISEASE COURSE; ERYTHEMA NODOSUM; ETHNICITY; FEMALE; FOLLOW UP; HUMAN; HYPERCALCEMIA; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEX RATIO;

ADULT; ARABS; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; KUWAIT; MALE; MIDDLE AGED; PROGNOSIS; SARCOIDOSIS, PULMONARY;

EID: 35348930467     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Mana J, Badrinas F: Prognosis of sarcoidosis. An unresolved issue. Sarcoidosis 1992; 9: 15-20.
2. Mana J, Salazar A, Pujol R, Manresa F: Are the pulmonary function tests and the markers of activity helpful to establish the prognosis of sarcoidosis? Respiration 1996; 63: 298-303.
3. Finkel R, Teirstein AS, Levine R, Brown LK, Miller A: Pulmonary function tests, serum angiotensin-converting enzyme levels, and clinical findings as prognostic indicators in sarcoidosis. Ann N Y Acad Sci 1986; 465: 665-71.
4. Poulter LW, Rossi GA, Bjermer L, et al: The value of bronchoalveolar lavage in the diagnosis and prognosis of sarcoidosis. Eur Respir J 1990; 3: 943-4.
5. Baughman RP, Shipley R, Eisentrout CE: Predictive value of gallium scan, angiotensin-converting enzyme level, and bronchoalveolar lavage in two-year follow-up of pulmonary sarcoidosis. Lung 1987; 165: 371-7.
6. Rutherford RM, Bratsche MH, Kearns M, Bourke M, Stevens F, Gilmartin JJ: HLA-DR2 predicts susceptibility and disease chronicity in Irish sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 191-8.
7. Sekiya M, Ohwada A, Miura K, Takahashi S, Fukuchi Y: Serum vascular endothelial growth factor as a possible prognostic indicator in sarcoidosis. Lung 2003; 181: 259-65.
8. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-55.
9. Pietinalho A, Furuya K, Yamaguchi E, Kawakami Y, Selroos O: The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients. Eur Respir J 1999; 13: 723-6.
10. Mana J, Montero A, Vidal M, Marcoval J, Pujol R: Recurrent sarcoidosis: a study of 17 patients with 24 episodes of recurrence. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 212-21.
11. Judson MA, Baughman RP, Thompson BW, et al: Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 204-11.
12. Viskum K, Vestbo J: Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage. Eur Respir J 1993; 6: 349-53.
13. Vatti R, Sharma OP: Course of asymptomatic liver involvement in sarcoidosis: role of therapy in selected cases. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14: 73-6.
14. Neville E, Walker AN, James DG: Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med 1983; 52: 525-33.
15. Mana J, Badrinas F, Manresa F, Valverde J, Fernandez-Nogues F: Predictive factors of the persistence of sarcoidosis activity 2 years after diagnosis. Med Clin (Barc) 1991; 97: 769-73.
16. Chevalet P, Clement R, Rodat O, Moreau A, Brisseau JM, Clarke JP: Sarcoidosis diagnosed in elderly subjects: retrospective study of 30 cases. Chest 2004; 126: 1423-30.
17. Gottlieb JE, Israel HL, Steiner RM, Triolo J, Patrick H: Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy. Chest 1997; 111: 623-31.
18. Pietinalho A, Ohmichi M, Lofroos AB, Hiraga Y, Selroos O: The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy-proven cases. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17: 158-66.
19. Israel HL, Gottlieb JE, Peters SP: The importance of ethnicity in the diagnosis and prognosis of sarcoidosis. Chest 1997; 111: 838-40.
20. Baughman RP, Winget DB, Bowen EH, Lower EE: Predicting respiratory failure in sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14: 154-8.
21. Milman N, Selroos O: Pulmonary sarcoidosis in the Nordic countries 1950-1982. II. Course and prognosis. Sarcoidosis 1990; 7: 113-8.
22. Siltzbach LE, James DG, Neville E, et al: Course and prognosis of sarcoidosis around the world. Am J Med 1974; 57: 847-52.
23. Reich JM: Mortality of intrathoracic sarcoidosis in referral vs population-based settings: influence of stage, ethnicity, and corticosteroid therapy. Chest 2002; 121: 32-9.
24. Shorr AF, Davies DB, Nathan SD: Predicting mortality in patients with sarcoidosis awaiting lung transplantation. Chest 2004; 124: 922-8.
25. Akira M, Kozuka T, Inoue Y, Sakatani M: Long-term follow-up CT scan evaluation in patients with pulmonary sarcoidosis. Chest 2005; 127: 185-91.
26. Ziegenhagen MW, Rothe ME, Schlaak M, Muller-Quernheim J: Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis. Eur Respir J 2003; 21: 407-13.
27. Krychniak-Soszka A, Kus J: Prognostic value of some clinical, radiological, laboratory and functional parameters in sarcoidosis. Pneumonol Alergol Pol 2002; 70: 573-82.
28. Miura K, Takahashi K, Fukuchi Y: Role of biochemical markers in sarcoidosis. Nippon Rinsho 2002; 60: 1741-6.
29. Baughman RP, Lower EE: The variability of sarcoidosis: can we predict it? Chest 2003; 123: 1329-32.